nlvpartners
  • Home
  • Approach
  • Team
  • Portfolio
  • About
  • News
  • Contact
Select Page

Intarcia Therapeutics

Active, Intarcia Therapeutics
Intarcia Therapeutics
← Principia Biopharma TigerConnect →

Recent Posts

  • News | October 23, 2019
  • News | November 21, 2019
  • News | November 18, 2019
  • News | November 5, 2019
  • News | November 7, 2019

Recent Comments

    Archives

    • December 2019
    • October 2019
    • September 2019
    • August 2019
    • June 2019
    • May 2019
    • March 2019
    • February 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • July 2017
    • June 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • July 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • August 2015
    • July 2015
    • June 2015
    • May 2015
    • April 2015
    • December 2014

    Categories

    • Aptinyx
    • Arvinas
    • Bright Insight
    • Deciphera
    • Edgewise
    • Interum
    • Kitcheck
    • Kyruus
    • Neurana
    • Neuronetics
    • New Leaf News
    • News 2013
    • News 2014
    • News 2015
    • News 2016
    • News 2017
    • News 2018
    • News 2019
    • PDS Biotechnology
    • Portfolio News
    • Principia
    • Sierra Oncology
    • TIgerConnect
    • Uncategorized

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org
    • Twitter

    Copyright © 2015 - 2019 New Leaf Venture Partners     |     New York City Phone: 646-871-6400     |     Menlo Park Phone: 650-234-2700     |     LP LOG-IN